Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.53 USD | +0.40% | -1.56% | +8.58% |
Apr. 04 | Transcript : VYNE Therapeutics Inc. - Special Call | |
Feb. 29 | VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on VYNE Therapeutics Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering VYNE Therapeutics Inc.
Cantor Fitzgerald | |
HC Wainwright | |
Northland Securities |
EPS Revisions
- Stock Market
- Equities
- VYNE Stock
- Consensus VYNE Therapeutics Inc.